scorecardresearch
Add as a preferred source on Google
Friday, March 6, 2026
TopicPharma

Topic: Pharma

Trump takes aim at branded pharma products with 100% tariff, unclear on generic drugs for now

The new tariffs, effective 1 October, are also aimed at kitchen cabinets, bathroom vanities & heavy trucks. Any levies on generic drugs could be a blow to Indian pharma exports to the US.

India has a substandard, fake drugs problem. Lack of recall law, scrutiny is making matters worse

Underlining need for more accountability, experts also stress that govt data does not include fixed dose combination drugs, which account for over 40% of drugs sold in India.

Panel will keep watch for violation of new drug marketing code, says pharma secretary

Implemented in March, UCPMP 2024 will look into complaints regarding unethical practices in sector. Code gains significance given that Patanjali is facing SC heat for misleading ads.

Govt move to review drug pricing mechanism triggers concern as pharma industry invited to join panel

Panel formed by Centre to review pricing framework for drugs & medical devices will have representatives from Indian Pharmaceutical Alliance & Indian Drug Manufacturers Association.

India denies nod to ‘1st-ever weekly insulin’ for diabetics, seeks more info from maker Novo Nordisk

Icodec has been touted as a therapy that could eliminate the need for daily or mealtime insulin injections for people with severe diabetes. It has not been approved by any country so far.

US lawsuit settlement puts spotlight back on ranitidine. India still undecided on ‘cancer-risk’ drug

Ranitidine still sold as popular heartburn medicine in India despite being banned or suspended in US, Europe & Australia. It was dropped from essential medicines list last year.

‘Diabetes capital’ India slated to get world’s 1st once-a-week insulin ‘by 2025’

Danish pharma giant Novo Nordisk's Icodec could be game-changer for diabetics. The drug is nearing regulatory approval in US & EU, says company.

Govt sets deadline for pharma MSMEs to adopt good manufacturing practices. ‘Follow or be penalised’

Health minister concedes implementation of Schedule M of Drugs and Cosmetics Act has been poor. Timeline for adherence to norms for good manufacturing practices began on 1 August.

Special inspection drive by drug controllers in 20 states, 26 pharma companies show-caused

The Drug Controller General of India (DCGI) has carried out nationwide inspections following a spate of incidents where drugs imported from India were found to be substandard or spurious.

Meth manufacturing drugs worth Rs 390 cr seized in Mizoram, probe suggests trafficking to Myanmar

Assam Rifles and the Mizoram customs department seized 39,04,000 triprolidine and pseudoephedrine tablets which act as precursors in manufacturing of addictive crystal methamphetamine.

On Camera

Will US waiver on Russian crude help India offset Middle East losses? What market analysts say

Indian refiners had been importing roughly 1 mbpd of Russian crude in the recent months, and the waiver will effectively allow them to lift volumes above this baseline.

Indian Navy says it deployed P-8I, diverted ships to boost efforts to rescue sunk Iran warship’s crew

Two Indian naval ships involved in the search and rescue operations in connection with IRIS Dena, which was operating 20 NM West of Galle in SAR region under Sri Lankan responsibility.

Pakistan is fighting a two-front war. I saw it coming 15 yrs ago

The Pakistani political leadership is weak and devoid of any intellect. Its diplomacy is entirely India-China-US focused and suffers from a presumptive view of Afghanistan as a vassal.